ADPT Adaptive Biotechnologies RESULTS: Q2, Q2 REV $71.553M vs. EST $65.9M, Q2 operating expenses $87.323M, Q2 Net Income $-39.941M, Q2 EPS $
ADPT Adaptive Biotechnologies RESULTS: Q2, Q2 REV $71.553M vs. EST $65.9M, Q2 operating expenses $87.323M, Q2 Net Income $-39.941M, Q2 EPS $-0.25, Q2 Operating Income $-15.77M, Q2 ADJ EBITDA $-700 thousand
Story updates
08:06:10 PM UTC
SquawkNews
ADPT Adaptive Biotechnologies RESULTS: Q2, Q2 REV $71.553M vs. EST $65.9M, Q2 operating expenses $87.323M, Q2 Net Income $-39.941M, Q2 EPS $-0.25, Q2 Operating Income $-15.77M, Q2 ADJ EBITDA $-700 thousand
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.